"COVID-19, caused by SARS-CoV-2, is initially characterized by acute lung injury and respiratory failure," said the study's senior author, Junbo Ge, M.D., professor and director of the Cardiology ...

A total of 43 patients who recovered from the SARS-CoV-2 infection with mild pneumonia were included along with 45 healthy ...

Research finds that 23% of people infected with SARS-CoV-2 between 2021 and 2023 developed long COVID, and in more than half ...

In pediatric patients aged 6 months to 5 years, the VE of mRNA-1273 against symptomatic infection was modest after a single dose and strong after a second dose.

The virus that causes COVID-19 has been very good at mutating to keep infecting people—so good that most antibody treatments ...

SARS-CoV-2 secondary structure shapes mutation frequencies, constraining viral evolution models predicting fitness can benefit from integrating secondary structure data.

Have we learned anything? This post examines past pandemics and the crucial lessons we must apply to future outbreaks.

A team has found two antibodies that can work together to neutralize the virus that causes COVID-19 in all its current known variations in a laboratory environment. More research is needed, but the ...

SARS-CoV-2 between 2021 and 2023 developed long-COVID, and in more than half of them the symptoms persisted for two years.